Table 1. Subjects in CDU TMA.
| N (%) | |
|---|---|
| Total | 204 |
| Ethnicity | |
| African American | 50 (24.5) |
| Hispanic | 28 (13.7) |
| Asian | 126 (61.8) |
| Age (yr) | |
| <50 | 90 (44.1) |
| ≥50 | 114 (55.9) |
| ERα/PR status | |
| Positive | 130 (63.7) |
| Negative | 74 (36.3) |
| HER2 status | |
| Positive (IHC 3+/FISH amplified) | 52 (25.5) |
| Negative | 152 (74.5) |
| Subtype (by receptors) | |
| ERα/PR+/HER2- | 104 (51.0) |
| HER2+ | 52 (25.5) |
| TNBC | 48 (23.5) |
| Tumor size | |
| ≤ 2cm | 45 (22.1) |
| 2cm – 5cm | 115 (56.4) |
| > 5cm | 32 (15.7) |
| Unknown | 12 (5.9) |
| Node | |
| Negative | 68 (33.3) |
| Positive | 127 (62.3) |
| Unknown | 9 (4.4) |
| Stage | |
| 0-II | 134 (65.7) |
| III-IV | 66 (32.4) |
| unknown | 4 (2.0) |
| ERβ (nuclear) | |
| Positive | 121 (59.3) |
| Negative | 83 (40.7) |
| IGF2 | |
| IGF2-positive | 41 (19.7) |
| IGF2-negative | 159 (76.4) |
| missing | 8 (3.8) |